Document is current

Article History

First Online: 8 January 2020

Compliance with Ethical Standards

:

: No external funding was used in the preparation of this manuscript.

: Dr N. Reguart reports receiving honoraria from AstraZeneca, Novartis, Takeda, Eli Lilly, MSD, Boehringer Ingelheim and Pfizer for consulting, advisory role or speaker’s bureaus; travel and accommodation expenses from Roche, MSD; and research funding from Pfizer and Novartis. C. Teixido reports receiving honoraria from Bristol-Myers Squibb, Pfizer and MSD for advisory role or speaker’s bureaus; travel and accommodation expenses from Roche, MSD; and research funding from Novartis. Jordi Remon reports receiving honoraria from Boehringer Ingelheim, Pfizer, MSD, Bristol-Myers Squibb and AstraZeneca for consulting, advisory role or speaker’s bureaus; travel and accommodation expenses from Bristol-Myers Squibb, OSE-Immunotherapeutics, AstraZeneca and Roche. Elba Marin and Roxana Reyes declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.